Glycoxidative modification of proteins in diabetes results in generation of neo-antigenic epitopes
confirmed by competitive-inhibition ELISA and gel retardation assays. The study shows that the neo-antigenic determinants on glycoxidatively modified proteins generate specific immune response in diabetes type-2, which

